Longitude Capital Partners III, LLC Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Longitude Capital Partners III, LLC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Longitude Capital Partners III, LLC. Longitude Capital Partners III, LLC is 10% Owner in Molecular Templates, Inc. ($MTEM) and 10% Owner in Sierra Oncology, Inc. ($SRRA) and 10% Owner in Axonics Modulation Technologies, Inc. ($AXNX) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in 89bio, Inc. ($ETNB) and 10% Owner in Talaris Therapeutics, Inc. ($TALS).

Latest Insider Trading Transactions of Longitude Capital Partners III, LLC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ETNB, AXNX, INZY, MTEM, SRRA, TALS

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
May 11 2021	TALS	Talaris Therapeuti ...	Longitude Capital Partners III ...	10% Owner	Option Exercise	C	0.00	406,338	0	0
May 11 2021	TALS	Talaris Therapeuti ...	Longitude Capital Partners III ...	10% Owner	Option Exercise	C	0.00	1,271,027	0	0
May 11 2021	TALS	Talaris Therapeuti ...	Longitude Capital Partners III ...	10% Owner	Option Exercise	C	0.00	1,308,410	0	0
May 11 2021	TALS	Talaris Therapeuti ...	Longitude Capital Partners III ...	10% Owner	Buy	P	17.00	235,000	3,995,000	3,220,775	3 M to 3.2 M (+7.87 %)
May 11 2021	TALS	Talaris Therapeuti ...	Longitude Capital Partners III ...	10% Owner	Buy	C	0.00	2,985,775	0	2,985,775	0 to 3 M
Sep 01 2020	MTEM	Molecular Template ...	Longitude Capital Partners III ...	10% Owner	Sell	S	10.75	1,049	11,273	0	1 K to 0 (-100.00 %)
Sep 01 2020	MTEM	Molecular Template ...	Longitude Capital Partners III ...	10% Owner	Sell	S	10.75	2,447	26,296	0	2.4 K to 0 (-100.00 %)
Jul 28 2020	INZY	Inozyme Pharma, In ...	Longitude Capital Partners III ...	10% Owner	Option Exercise	C	0.00	1,398,600	0	0
Jul 28 2020	INZY	Inozyme Pharma, In ...	Longitude Capital Partners III ...	10% Owner	Option Exercise	C	0.00	15,000,000	0	0
Jul 28 2020	INZY	Inozyme Pharma, In ...	Longitude Capital Partners III ...	10% Owner	Buy	P	16.00	625,000	10,000,000	2,819,379	2.2 M to 2.8 M (+28.48 %)
Jul 28 2020	INZY	Inozyme Pharma, In ...	Longitude Capital Partners III ...	10% Owner	Buy	C	0.00	187,154	0	2,194,379	2 M to 2.2 M (+9.32 %)
Jul 28 2020	INZY	Inozyme Pharma, In ...	Longitude Capital Partners III ...	10% Owner	Buy	C	0.00	2,007,225	0	2,007,225	0 to 2 M
Jul 14 2020	ETNB	89bio, Inc.	Longitude Capital Partners III ...	10% Owner	Buy	P	27.50	109,090	2,999,975	2,600,877	2.5 M to 2.6 M (+4.38 %)
May 28 2020	MTEM	Molecular Template ...	Longitude Capital Partners III ...	10% Owner	Buy	J	0.00	1,049	0	1,049	0 to 1 K
May 28 2020	MTEM	Molecular Template ...	Longitude Capital Partners III ...	10% Owner	Buy	J	0.00	2,447	0	2,447	0 to 2.4 K
May 28 2020	MTEM	Molecular Template ...	Longitude Capital Partners III ...	10% Owner	Buy	J	0.00	3,495	0	3,495	0 to 3.5 K
May 28 2020	MTEM	Molecular Template ...	Longitude Capital Partners III ...	10% Owner	Sell	J	0.00	1,000,000	0	3,199,035	4.2 M to 3.2 M (-23.81 %)
Jan 31 2020	SRRA	Sierra Oncology, I ...	Longitude Capital Partners III ...	10% Owner	Option Exercise	C	0.00	19,500	0	0
Jan 31 2020	SRRA	Sierra Oncology, I ...	Longitude Capital Partners III ...	10% Owner	Buy	C	0.00	1,477,320	0	1,477,320	0 to 1.5 M
Nov 27 2019	MTEM	Molecular Template ...	Longitude Capital Partners III ...	10% Owner	Buy	P	8.00	937,000	7,496,000	4,198,535	3.3 M to 4.2 M (+28.73 %)
Nov 13 2019	ETNB	89bio, Inc.	Longitude Capital Partners III ...	10% Owner	Option Exercise	C	0.00	11,916,667	0	0
Nov 13 2019	ETNB	89bio, Inc.	Longitude Capital Partners III ...	10% Owner	Option Exercise	C	0.00	11,916,667	0	0
Nov 13 2019	ETNB	89bio, Inc.	Longitude Capital Partners III ...	10% Owner	Buy	C	0.00	1,916,787	0	2,491,787	575 K to 2.5 M (+333.35 %)
Nov 13 2019	ETNB	89bio, Inc.	Longitude Capital Partners III ...	10% Owner	Buy	C	0.00	1,916,787	0	2,491,787	575 K to 2.5 M (+333.35 %)
Nov 13 2019	ETNB	89bio, Inc.	Longitude Capital Partners III ...	10% Owner	Buy	P	16.00	575,000	9,200,000	575,000	0 to 575 K
Nov 13 2019	ETNB	89bio, Inc.	Longitude Capital Partners III ...	10% Owner	Buy	P	16.00	575,000	9,200,000	575,000	0 to 575 K
Nov 02 2018	AXNX	Axonics Modulation ...	Longitude Capital Partners III ...	10% Owner	Option Exercise	C	0.00	2,000,000	0	0
Nov 02 2018	AXNX	Axonics Modulation ...	Longitude Capital Partners III ...	10% Owner	Buy	P	15.00	533,333	7,999,995	2,933,333	2.4 M to 2.9 M (+22.22 %)
Nov 02 2018	AXNX	Axonics Modulation ...	Longitude Capital Partners III ...	10% Owner	Buy	C	0.00	2,400,000	0	2,400,000	0 to 2.4 M
Sep 25 2018	MTEM	Molecular Template ...	Longitude Capital Partners III ...	10% Owner	Buy	P	5.50	365,000	2,007,500	3,261,535	2.9 M to 3.3 M (+12.60 %)
Sep 25 2018	MTEM	Molecular Template ...	Longitude Capital Partners III ...	10% Owner	Buy	P	5.50	365,000	2,007,500	3,261,535	2.9 M to 3.3 M (+12.60 %)

Page: 1